Shilpa Medicare Limited has scheduled a Board of Directors meeting on May 22, 2026, to review and approve the company’s standalone and consolidated financial results for the fourth quarter and the financial year ended March 31, 2026. Additionally, the board will deliberate on a potential dividend recommendation for the 2025-26 fiscal year.
Upcoming Board Meeting Details
The management of Shilpa Medicare Limited has announced that a board meeting is set for Friday, May 22, 2026. The primary objective of this session is to evaluate the company’s performance for the fourth quarter (January-March) and the full financial year concluded on March 31, 2026. Investors can expect the release of both standalone and consolidated audit reports along with the official financial statements following the conclusion of this meeting.
Dividend Consideration
In addition to reviewing financial performance, the Board of Directors will discuss the recommendation of a dividend for the financial year 2025-26. If approved, this would provide a direct return to shareholders for the preceding fiscal year, subject to final approval at the upcoming Annual General Meeting.
Trading Window Restrictions
To maintain regulatory compliance and prevent insider trading, the company has implemented a trading window closure. This restriction has been in effect since April 01, 2026. The window will remain closed for designated persons until 48 hours after the official declaration of the audited financial results, ensuring price-sensitive information is managed securely prior to public dissemination.
Source: BSE
